RPP nxtag( IVD-US) 96 tests

Ended Awarded Last action

Contract number
W9114F25F0008
Awardee
Awarding agency
Obligated
$148,445

Award facts

Opportunity
  • W9114F23Q0070 Solicitation number
Contract value 100% obligated
$148,444.76 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
NAICS code
339113 Surgical Appliance and Supplies Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Competed under SAP Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Germany

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency awarded a $148.4K firm fixed-price delivery order to Diasorin Deutschland GMBH on December 1, 2024, for RPP NXTAG (IVD-US) 96 test kits, with completion scheduled for September 30, 2025. This delivery order was issued without a set-aside designation and represents a direct acquisition of respiratory pathogen panel diagnostic testing supplies from the Germany-based manufacturer. Diasorin Deutschland GMBH, a foreign-owned in-vitro diagnostic products manufacturer based in Dietzenbach, is well-positioned to serve U.S. military medical facilities in the European theater, with performance taking place in Germany.

This delivery order is issued under a single-award indefinite delivery contract valued at $732.6K that was established with Diasorin Deutschland GMBH on September 5, 2023, and extends through September 4, 2028. The underlying IDV framework enables the Defense Health Agency to procure medical testing supplies and laboratory equipment on an as-needed basis to support operations at Landstuhl Regional Medical Center, a major U.S. military medical facility. As of early 2026, three delivery orders totaling approximately $453.8K have been issued under this contract vehicle, demonstrating sustained operational demand for the company's specialized diagnostic products in support of U.S. military medical readiness in Europe.

Quick answers

Who was awarded contract W9114F25F0008?

W9114F25F0008 was awarded to Diasorin Deutschland GMBH by Medical Command (Department of the Army) on December 1, 2024.

How much is contract W9114F25F0008 worth?

The government has obligated $148,445 on W9114F25F0008.

Which agency awarded contract W9114F25F0008?

Medical Command (Department of the Army) awarded W9114F25F0008, with funding from Defense Health Agency (Department of Defense).

Is contract W9114F25F0008 an order under another contract?

Yes. W9114F25F0008 is a delivery order under W9114F23D0007, an indefinite delivery contract.

Was contract W9114F25F0008 competed?

The extent of competition for W9114F25F0008 was competed under sap.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award